【摘要】：探討顱內(nèi)間變性腦膜瘤的治療及預(yù)后分析。對(duì)筆者所在醫(yī)院2010年1月~2014年1月接受顱內(nèi)間變性腦膜瘤治療的患者50例,對(duì)其臨床資料進(jìn)行分析,分析預(yù)后相關(guān)因素。50例患者均為顱內(nèi)間變性(惡性)腦膜瘤。所有患者按照Simpson分級(jí)法評(píng)估術(shù)后腫瘤切除的程度,其中26例患者接受SimpsonⅠ級(jí)切除;24例患者接受SimpsonⅡ級(jí)、Ⅲ級(jí)切除。50例患者分為四組,其中SimpsonⅠ級(jí)切除合并放療組13例,SimpsonⅠ級(jí)切除無(wú)放療組13例,SimpsonⅡ級(jí)、Ⅲ級(jí)切除合并放療組12例,SimpsonⅡ級(jí)、Ⅲ級(jí)切除無(wú)放療組12例。SimpsonⅠ級(jí)切除合并放療組的無(wú)進(jìn)展生存期(PFS)為68個(gè)月,復(fù)發(fā)率為48%。SimpsonⅠ級(jí)切除無(wú)放療組PFS為22個(gè)月,復(fù)發(fā)率為90%。SimpsonⅡ級(jí)、Ⅲ級(jí)切除合并放療組PFS為23個(gè)月,復(fù)發(fā)率為87%。SimpsonⅡ級(jí)、Ⅲ級(jí)切除無(wú)放療組PFS為12個(gè)月,復(fù)發(fā)率為92%。SimpsonⅠ級(jí)切除合并術(shù)后放療是有效治療顱內(nèi)間變性腦膜瘤并延長(zhǎng)生存率的有效治療方法。
[Abstract]:To investigate the treatment and prognosis of intracranial anaplastic meningioma. From January 2010 to January 2014, 50 patients with intracranial anaplastic meningioma were treated in our hospital. The clinical data were analyzed. The prognostic factors of 50 patients were all intracranial anaplastic (malignant) meningioma. All the patients were evaluated for the degree of tumor resection according to the Simpson grading method. Among them, 26 patients received Simpson grade 鈪，

本文編號(hào)：2178607